driven by scientific excellence and boundless curiosity

Who We Are

To unlock the power of RNA and enable the advancement of transformative medicine

As protein drug discovery continued to exhaust low-hanging fruits, we founded Nymirum in 2009 to tackle a new and challenging frontier filled with untapped therapeutic potential: targeting RNA with small molecules.


On this mission, we are driven by scientific rigor, uninhibited curiosity, the spirit of collaboration, integrity, and most importantly, the duty to do good for the world.

Company Leadership

Joshua P. Fairbank

Chief Executive Officer

Hashim Al-Hashimi

Inventor and Platform Architect

Isaac Kimsey

Vice President,

Drug Discovery

Yang Zheng

Head of Business Development

Michael Pape



Chicago, IL 60611

Durham, NC 27713

© 2020 by Nymirum Inc. All rights reserved.